心脏转移瘤放疗的研究进展  

Progress in the diagnosis and treatment of radiotherapy for cardiac metastases

作　　者：徐铁 梁军 Xu Tie;Liang Jun(Department of Radiation Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital&Shenzhen Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Shenzhen 518116,China)

机构地区：[1]国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院深圳医院放疗科,深圳518116

出　　处：《中华放射肿瘤学杂志》2025年第3期295-299,共5页Chinese Journal of Radiation Oncology

基　　金：深圳市高水平医院建设专项经费。

摘　　要：心脏肿瘤很少见,绝大多数是转移性的。发生心脏转移的患者大多已是肿瘤终末期,5年生存率几乎为零。由于发病率较低,目前尚无心脏转移患者的标准治疗方案。由于放疗可能导致心脏不良反应,姑息性放疗在心脏转移患者中的使用受限。本文从患者定位、靶区勾画、剂量设置、危及器官限量、不良反应等方面对心脏转移患者的放疗实践及研究进展进行综述。Cardiac tumors are rare,and the majority of them are metastatic.Most patients with cardiac metastasis are in the terminal stage of cancer,and the 5-year survival rate is almost zero.Due to the low morbidity,there is no standard therapy for the management of patients with cardiac metastases.The use of palliative radiotherapy in patients with cardiac metastasis is limited due to the adverse cardiac effects caused by radiotherapy.This article reviews the practice and progress in radiotherapy for patients with cardiac metastases from the aspects of positioning,target delineation,dose setting,organ at risk limit,and side effects.

关 键 词：肿瘤转移 心脏 放射疗法 研究进展 

分 类 号：R73[医药卫生—肿瘤]